Vetnostrum Animal Health Co., Ltd. (TWSE: 6936)
Health Care · Pharmaceuticals · TW
NT$32.05
+0.47% today · -8.9% 1Y
Vetnostrum Animal Health Co., Ltd. (TWSE: 6936) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $72.93M and employs 195 people.
Over the last twelve months the share price has lost 8.9%, trading between 31.50 and 46.20.
Tweenvest scores Vetnostrum Animal Health Co., Ltd. across four factors: quality 70/100, value 78/100, dividend 88/100. Its strongest factor is dividend.
6936 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $72.93M
- Revenue (TTM)
- $45.15M
- P/E
- 16.90
- EPS
- 1.90
- Dividend yield
- 4.71%
- Beta (5Y)
- 0.10
- 52-week high
- NT$46.20
- 52-week low
- NT$31.50
- Avg volume (3M)
- —
- Shares outstanding
- 72.80M
- Employees
- 195
- Next earnings
- —
About Vetnostrum Animal Health Co., Ltd.
Vetnostrum is a company focused on animal health products, including veterinary medicines, functional feed additives, and nutritional supplements for both livestock and companion animals. As one of Taiwan's leading large-scale veterinary pharmaceutical manufacturers, it leverages human-grade pharmaceutical standards across its R&D and production. The company holds numerous domestic and international product licenses and serves clients like feed mills, livestock farms, and veterinary hospitals, while also developing its own pet brand, Koolpal.
- ISIN
- TW0006936008
- Founded
- 2012
- Listed since
- Mar 24, 2023
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.